LONDON, March 10, 2014 /PRNewswire/ --

On Friday, March 07, 2014, the US markets saw a mixed sentiment, with the NASDAQ Composite closing at 4,336.22, down 0.37%, the Dow Jones Industrial Average ending the session at 16,452.72, up 0.19% and the S&P 500 edging 0.05% higher to finish the trading session at 1,878.04. During the session gains in the Financials, Energy and Industrials sectors positively impacted the broader market, while some retraction came in from Health Care, Materials and Information Technology sectors. A number of stocks saw large movements, including Cel-Sci Corporation (NYSE MKT: CVM), RadioShack Corporation (NYSE: RSH), Penn West Petroleum Ltd (NYSE: PWE), and Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR), which were amongst the top gainers for the session. Free research on these four companies can be accessed at:  

http://investor-edge.com/register

Cel-Sci Corp.'s stock finished Friday's session at $1.41, recording a gain of 11.90%. A total of 7.41 million shares traded which is above the three months average volume of 2.19 million shares. The stock vacillated between $1.30 and $1.52 during the session. The company's shares have rallied 25.89% in the previous three trading sessions and 80.77% in the last three months. Cel-Sci Corp.'s shares have gone up 138.23% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 0.21% during the trading session and charted up 8.01% in the previous three months. Additionally, the stock is trading at the RSI of 71.86 and above its 50-day moving average of $0.97. Sign up and read the free notes on CVM at:

http://www.Investor-Edge.com/03102014/CVM/report.pdf

RadioShack Corp.'s stock edged 5.39% higher, finishing Friday's session at $2.15, with 4.17 million shares traded during the session as compared to a three months average volume of 3.26 million shares. The stock fluctuated between $2.05 and $2.18 during the trading session. Despite Friday's gains, RadioShack Corp.'s shares have lost 4.44% in the previous three trading sessions and have gone down by 17.31% on YTD basis. The S&P 500 Consumer Discretionary Sector Index mapped a loss of 0.11% during the trading session and charted up 5.05% in the last one month. Furthermore, the stock is trading at the RSI of 39.10 and below its 50-day and 200-day moving averages of $2.43 and $2.97, respectively. The complimentary notes on RSH can be downloaded as in PDF format at:

http://www.Investor-Edge.com/03102014/RSH/report.pdf

On Friday, shares in Penn West Petroleum Ltd ended the day at $8.50, which is 7.32% higher than the previous day's closing price of $7.92. A total of 4.94 million shares were traded as compared to the three months average volume of 2.38 million shares. During the session, the stock oscillated between $7.65 and $8.55. The company's shares have advanced 4.42% in the previous three trading sessions and 8.56% in the last one month. Penn West Petroleum Ltd's shares have gone up 1.67% on YTD basis. The S&P 500 Energy Sector Index mapped a gain of 0.40% during the trading session and charted up 5.06% in the last one month. Furthermore, the stock is trading at the RSI of 61.63 and above its 50-day moving average of $8.04. Register for free on Investor-Edge and access the latest research on PWE at:

http://www.Investor-Edge.com/03102014/PWE/report.pdf

Shares in Aegerion Pharmaceuticals Inc. closed Friday's session at $55.53, up 10.60% with a trading volume of 3.74 million shares as compared to a three months average volume of 0.85 million shares. The stock traded between $47.11 and $58.08 during the session. Despite Friday's gains, Aegerion Pharmaceuticals Inc.'s shares have fallen by 2.24% in the previous three trading sessions and have declined 21.74% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 0.21% during the trading session and charted up 4.51% in the last one month. Moreover, the stock is trading at the RSI of 42.75 and below its 50-day and 200-day moving averages of $62.83 and $74.54, respectively. The complete research on AEGR is available for free at:

http://www.Investor-Edge.com/03102014/AEGR/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

EDITOR NOTES:

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] Investor-edge.com.
  • For any urgent concerns or inquiries, please contact us at compliance [at] Investor-edge.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] Investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

Copyright 2014 PR Newswire

Cel Sci (AMEX:CVM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cel Sci Charts.
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cel Sci Charts.